Overview

Update
Investments
1 Investment in 1 Company
IPO / Stock
Went Public on Apr 4, 2014 / NASDAQ:AGTC
Headquarters:
Alachua, FL
Description:
Applied Genetics Technologies develops cures for rare lung and eye diseases.
Founders:
, , , ,
Categories:
Pharmaceutical, Biotechnology, Developer Platform
Website:
http://agtc.com
Social:

Company Details

Update

Applied Genetic Technologies Corporation (AGTC) was founded by five scientific leaders in the use of viral vectors for Gene Therapy and began operations in 2001. They subsequently secured rights to a portfolio of strategically vital intellectual property in the application of Adeno-Associated Virus (AAV) to gene therapy. Since that time the Company has signed licenses to over 40 US and foreign patents, raised over $45M in venture financing from blue chip investors and has five products in active development, one of which is partnered to Genzyme Corporation.

AGTC's most recent round of financing was completed in April 2009 and was led by Interwest Partners of Menlo Park, CA. Other investors included Intersouth Partners of RTP, NC and MedImmune Ventures of Gaithersburg, MD.

Funding Rounds (5) - $78.05M

Update
DateAmount / RoundValuationLead InvestorInvestors
Nov, 2012$37.5M / Series B6
May, 2012$750k / Debt Financing0
Sep, 2010$1M / Grant0
Jun, 2009$11.8M / Venture3
Nov, 2003$27M / Series B4

Investments (1)

DateInvested InRoundPartner(s)
Mar, 2001undisclosed amount / Series B (Lead)

Current Team (10)

Update

Offices/Locations (1)

Update
  • Headquarters

    11801 Research Drive

    Suite D

    Alachua, FL 32615

    USA

Past Team (1)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos